| Literature DB >> 17692530 |
Evanthia Diamanti-Kandarakis1, Athanasios G Papavassiliou, Stylianos A Kandarakis, George P Chrousos.
Abstract
Polycystic ovary syndrome (PCOS) is an endocrinopathy that affects women of reproductive age. PCOS shares components with the metabolic syndrome and has broad health implications. Lipid abnormalities, including elevated low-density lipoprotein (LDL), triglyceride levels and decreased high-density lipoprotein (HDL), are often found in women with PCOS. It is clear that obesity, insulin resistance and hyperandrogenism coexist in PCOS, and have independent and interactive effects on dyslipidemia, although the mechanisms of these interactions remain elusive. Here, we review the types and pathophysiology of dyslipidemia associated with PCOS and its related conditions.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17692530 DOI: 10.1016/j.tem.2007.07.004
Source DB: PubMed Journal: Trends Endocrinol Metab ISSN: 1043-2760 Impact factor: 12.015